Transient corneal endothelial changes following accelerated collagen cross-linking for the treatment of progressive keratoconus

Cutaneous and Ocular Toxicology

Volumn 33, Issue 2, 2014, Pages 127-131

  Cingü, Abdullah Kürşat ^a   Sogutlu Sari, Esin ^b   Çinar, Yasin ^a   Şahin, Muhammed ^a   Türkçü, Fatih Mehmet ^a   Yüksel, Harun ^a   Şahin, Alparslan ^a   Çaça, Ihsan ^a  

^a DICLE UNIVERSITY   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Accelerated CXL; Corneal endothelium; Riboflavin

Indexed keywords

COLLAGEN; DEXTRAN; FLUOROMETHOLONE; MEDIOCROSS M ISOTONIC; MOXIFLOXACIN; RIBOFLAVIN; UNCLASSIFIED DRUG; PHOTOSENSITIZING AGENT;

ADULT; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; COLLAGEN CROSS LINKAGE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA SURGERY; ENDOTHELIAL CELL DENSITY; ENDOTHELIUM CELL; EPITHELIZATION; EYE; FEMALE; HUMAN; HUMAN CELL; KERATOCONUS; MALE; PATIENT SAFETY; POSTOPERATIVE INFECTION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROTEIN CROSS LINKING; SPECULAR MICROSCOPY; ULTRAVIOLET A RADIATION; VISUAL ACUITY; YOUNG ADULT; ADOLESCENT; CHILD; CONTROLLED CLINICAL TRIAL; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; CHILD; COLLAGEN; ENDOTHELIUM, CORNEAL; FEMALE; HUMANS; KERATOCONUS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84901345893     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2013.812107     Document Type: Article

References (23)

1. Wittig-Silva C, Whiting M, Lamoureux E, et al. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg 2008;24: S720-S725.
2. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-627.
3. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg 2008;34:796-801.
4. Wollensak G, Sporl E, Seiler T. Treatment of keratoconus by collagen cross linking. Ophthalmologe 2003;100:44-49.
5. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea 2007;26:385-389.
6. Wollensak G, Sporl E, Reber F, et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 2003;35:324-328.
7. Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 2009;25:S824-S828.
8. Kymionis GD, Portaliou DM, Bouzoukis DI, et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 2007;33: 1982-1984.
9. Wollensak G, Hammer T, Herrmann CI. Haze or calcific band keratopathy after crosslinking treatment? Ophthalmologe 2008; 105:864-865.
10. O'Brart DP, Chan E, Samaras K, et al. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol 2011;95:1519-1524.
11. Kolli S, Aslanides IM. Safety and efficacy of collagen crosslinking for the treatment of keratoconus. Expert Opin Drug Saf 2010;9:949-957.
12. Goldich Y, Marcovich AL, Barkana Y, et al. Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus. Cornea 2010;29:409-411.
13. Matalia H JA, Kumar M, Shetty R. Is accelerated corneal collagen cross-linking a safe procedure? A pilot study. ESCRS 2012, free paper 2012.
14. Gokhale NS. Corneal endothelial damage after collagen crosslinking treatment. Cornea 2011;30:1495-1498.
15. Sharma A, Nottage JM, Mirchia K, et al. Persistent corneal edema after collagen cross-linking for keratoconus. Am J Ophthalmol 2012;154:922-926.
16. C?nar Y, Cingu AK, Sahin A, et al. Intraoperative corneal thickness measurements during corneal collagen cross-linking with isotonic riboflavin solution without dextran in corneal ectasia. Cutan Ocul Toxicol 2013 May 21. [Epub ahead of print]. doi:10.3109/15569527.2013.793700.
17. Matsuda M, Suda T, Manabe R. Quantitative analysis of endothelial mosaic pattern changes in anterior keratoconus. Am J Ophthalmol 1984;98:43-49.
18. Laing RA, Sandstrom MM, Berrospi AR, Leibowitz HM. The human corneal endothelium in keratoconus: a specular microscopic study. Arch Ophthalmol 1979;97:1867-1869.
19. Mocan MC, Yilmaz PT, Irkec M, Orhan M. In vivo confocal microscopy for the evaluation of corneal microstructure in keratoconus. Curr Eye Res 2008;33:933-939.
20. Ucakhan OO, Kanpolat A, Ylmaz N, Ozkan M. In vivo confocal microscopy findings in keratoconus. Eye Contact Lens 2006;32: 183-191.
21. Benetz BA, Yee R, Bidros M, Lass J. Imaging techniques of cornea: specular microscopy. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. 3rd ed. New York: Mosby Elsevier; 2011:14:177-204.
22. Touboul D, Efron N, Smadja D, et al. Corneal confocal microscopy following conventional, transepithelial, and accelerated corneal collagen cross-linking procedures for keratoconus. J Refract Surg 2012;28:769-776.
23. Cui L, Huxlin KR, Xu L, et al. High-resolution, noninvasive, twophoton fluorescence measurement of molecular concentrations in corneal tissue. Invest Ophthalmol Vis Sci 2011;52:2556-2564.